20% subcutaneous immunoglobulin dosed biweekly for primary immunodeficiency

被引：4
|
作者：
Wasserman, Richard L. [1 ]
Stein, Mark R. [2 ]
Younger, M. Elizabeth M. [2 ]
Fatteh, Shahnaz [3 ]
Haddad, Elie [4 ,5 ]
机构：
[1] Allergy Partners North Texas Res, Dallas, TX USA
[2] Allergy Associates Palm Beaches, North Palm Beach, FL USA
[3] Larkin Community Hosp, South Miami, FL USA
[4] Univ Montreal, CHU St Justine, Dept Pediat, Montreal, PQ, Canada
[5] Univ Montreal, CHU St Justine, Dept Microbiol Infectiol & Immunol, Montreal, PQ, Canada
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2016年 / 117卷 / 01期
关键词：
REPLACEMENT THERAPY; EFFICACY; SAFETY; IGPRO20; DISEASE;
D O I：
10.1016/j.anai.2016.04.023
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：93 / 94
页数：2
相关论文
共 50 条
  • [21] Patient experience with subcutaneous immunoglobulin 20%, Ig20Gly, for primary immunodeficiency diseases: a prespecified post hoc analysis of combined data from 2 pivotal trials
    Meckley, Lisa M.
    Wu, Yanyu
    Ito, Diane
    Berner, Todd
    McCoy, Barbara
    Yel, Leman
    BMC IMMUNOLOGY, 2020, 21 (01)
  • [22] Real-World Use, Safety, and Patient Experience of 20% Subcutaneous Immunoglobulin for Primary Immunodeficiency Diseases
    Fasshauer, Maria
    Borte, Michael
    Bitzenhofer, Michaela
    Pausch, Christine
    Pittrow, David
    Park, Michelle
    Gladiator, Andre
    Jandus, Peter
    ADVANCES IN THERAPY, 2023, 40 (12) : 5168 - 5187
  • [23] Efficacy and Safety of Hizentra®, a New 20% Immunoglobulin Preparation for Subcutaneous Administration, in Pediatric Patients with Primary Immunodeficiency
    Borte, Michael
    Pac, Malgorzata
    Serban, Margit
    Gonzalez-Quevedo, Teresa
    Grimbacher, Bodo
    Jolles, Stephen
    Zenker, Othmar
    Neufang-Hueber, Jutta
    Belohradsky, Bernd
    JOURNAL OF CLINICAL IMMUNOLOGY, 2011, 31 (05) : 752 - 761
  • [24] Pharmacokinetic Analysis of Weekly Versus Biweekly IgPro20 Dosing in Patients With Primary Immunodeficiency
    Rojavin, Mikhail A.
    Chapdelaine, Hugo
    Tortorici, Michael A.
    Praus, Michaela
    Baheti, Gautam
    Zhang, Ying
    Hofmann, Jutta
    Labrosse, Roxane
    Dicaire, Renee
    Haddad, Elie
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2020, 9 (06): : 664 - 670
  • [25] Safety, efficiency, and treatment satisfaction in children with primary immunodeficiency receiving subcutaneous immunoglobulin treatment
    Eltan, Sevgi Bilgic
    Keskin, Ozlem
    Deveci, Mehmet Fatih
    NORTHERN CLINICS OF ISTANBUL, 2022, 9 (03) : 228 - 234
  • [26] Recombinant human hyaluronidase-facilitated subcutaneous immunoglobulin infusion in primary immunodeficiency diseases
    Wasserman, Richard L.
    IMMUNOTHERAPY, 2017, 9 (12) : 1035 - 1050
  • [27] Tolerability of subcutaneous immunoglobulin 20%, Ig20Gly, in pediatric patients with primary immunodeficiencies
    Paris, Kenneth
    Haddad, Elie
    Borte, Michael
    Brodszki, Nicholas
    Derfalvi, Beata
    Marodi, Laszlo
    Hussain, Iftikhar
    Darter, Amy
    Engl, Werner
    Leibl, Heinz
    McCoy, Barbara
    Yel, Leman
    IMMUNOTHERAPY, 2019, 11 (05) : 397 - 406
  • [28] Population pharmacokinetic analysis of weekly and biweekly IgPro20 (Hizentra®) dosing in patients with primary immunodeficiency
    Zhang, Ying
    Baheti, Gautam
    Chapdelaine, Hugo
    Hofmann, Jutta
    Rojavin, Mikhail
    Tortorici, Michael
    Haddad, Elie
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 81
  • [29] Improved Quality of Life, Immunoglobulin G Levels, and Infection Rates in Patients with Primary Immunodeficiency Diseases during Self-Treatment with Subcutaneous Immunoglobulin G
    Berger, Melvin
    Murphy, Elyse
    Riley, Patty
    Bergman, Garrett E.
    SOUTHERN MEDICAL JOURNAL, 2010, 103 (09) : 856 - 863
  • [30] Shift from intravenous or 16% subcutaneous replacement therapy to 20% subcutaneous immunoglobulin in patients with primary antibody deficiencies
    Canessa, Clementina
    Iacopelli, Jessica
    Pecoraro, Antonio
    Spadaro, Giuseppe
    Matucci, Andrea
    Milito, Cinzia
    Vultaggio, Alessandra
    Agostini, Carlo
    Cinetto, Francesco
    Danieli, Maria Giovanna
    Gambini, Simona
    Marasco, Carolina
    Trizzino, Antonino
    Vacca, Angelo
    De Mattia, Domenico
    Martire, Baldassarre
    Plebani, Alessandro
    Di Gioacchino, Mario
    Gatta, Alessia
    Finocchi, Andrea
    Licciardi, Francesco
    Martino, Silvana
    De Carli, Marco
    Moschese, Viviana
    Azzari, Chiara
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2017, 30 (01) : 73 - 82
12345